Johnson & Johnson (JNJ) Other financing activities (2009 - 2026)

Johnson & Johnson has disclosed Other financing activities across 15 years of filings, most recently posting -$588.0 million for Q1 2026.

• In Q1 2026, Other financing activities fell 1570.0% year-over-year to -$588.0 million; the TTM figure through Jun 2026 stood at -$663.0 million (down 1850.0% YoY), while the FY2025 annual figure was -$34.0 million, up 10.53% from the prior year.
• Other financing activities came in at -$588.0 million for Q1 2026 at Johnson & Johnson, down from -$26.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.5 billion in Q3 2023 to a low of -$588.0 million in Q1 2026.
• Average Other financing activities over 5 years is $286.2 million, with a median of -$37.5 million recorded in 2025.
• Year-over-year, Other financing activities surged 138.91% in 2024 and plunged 1570.0% in 2026.
• Over 5 years, Other financing activities stood at -$138.0 million in 2022, then surged by 3346.38% to $4.5 billion in 2023, then plunged by 101.67% to -$75.0 million in 2024, then surged by 65.33% to -$26.0 million in 2025, then plunged by 2161.54% to -$588.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were -$588.0 million in Q1 2026, -$26.0 million in Q4 2025, and -$49.0 million in Q3 2025.